FDA Dietary Supplement Enforcement Enters Epidemiological Trend Era
This article was originally published in The Tan Sheet
Executive Summary
FDA is shifting away from microbiological to epidemiological data to justify enforcement on potential safety risks, NPA President Fabricant says. Other efforts include rooting out noncompliant advertising claims, harmonizing import alert enforcement and improving compliance with NDI notification requirements.